photo of Georgios Giamas

Prof Georgios Giamas

Post:Professor of Cancer Cell Signalling (Biochemistry)
Location:JMS BUILDING 3C12
Email:G.Giamas@sussex.ac.uk

Telephone numbers
Internal:3163
UK:01273 873163
International:+44 1273 873163

Research expertise:
download vCarddownload vCard to your mobile

Biography

Professor Georgios Giamas obtained his Biology degree (BSc) at the National and Kapodistrian University of Athens in Greece. He then undertook his Doctoral degree (PhD - Magna Cum Laude) at the University of Ulm (Germany). Following postdoctoral work at the University of Ulm, he moved to Imperial College London at 2007, working as a Research Associate in the Division of Surgery and Cancer. In 2011 he was awarded Imperial College's prestigious Junior Research Fellowship. In 2012 he was awarded a NIHR Senior Research Fellowship and was appointed as a Research Team Leader. In July 2015, he became a Reader (Associate Professor) in Cell Signalling at University of Sussex. Since May 2018, he is a Professor at the department of Biochemistry and Biomedicine at University of Sussex  while holding an honorary contract (Visiting Professor) at Imperial College.

Professor Giamas is an Associate Fellow of the Higher Education Academy and is the Designated Individual (DI) under the Human Tissue Act in the School of Life Sciences.

Role

Professor of Cancer Cell Signalling

 

Editorial boards and Peer reviewing

  • Deputy Editor in Oncogene (Nature/Springer).
  • Editoria Board of Communications Biology (Nature/Springer)
  • Advisory Board member of ‘Cellular and Molecular Life Sciences’ (Springer)
  • Member of the Editorial Board of: Scientific Reports and Breast Cancer Management Journals.
  • Peer Reviewer for scientific journals including: Annals of Oncology, Molecular Cancer Therapeutics, British Journal of Cancer, Pharmacogenomics journal, Clinical Epigenetics, International Journal of Cancer, BMC Cell Biology, Scientific Reports, Breast Cancer, Expert Opinion on Drug Discovery, Medicinal Research Reviews, Plos One, Advances in Breast Cancer, Experimental and Therapeutic Medicine,  Clinical Colorectal Cancer and others
  • Peer Reviewer for research grants applications from Medical Research Council (MRC; UK), Worldwide Cancer Research, NC3Rs, Breast Cancer Now (BCN; UK), Neuroblastoma UK, Bloodwise (UK), Yorkshire Cancer Research (UK), MIUR (the Italian Ministry for Education, University and Research), John Goldman Fellowships Austrian Science Fund (FWF), National Science Centre (Poland) and other international research bodies

 

Member  of Professional Bodies

  • ASCO (American Association for Clinical Oncology
  • Association of Union for International Cancer Control (UICC)
  • American Association for Cancer Research (AACR)
  • The European Association for Cancer Research (EACR)